PATENT CLAIM ANALYSIS

Application Number: 16152288
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["424", "452000"]

Abstract:
The present invention provides immediate release abuse resistant or deterrent formulations such as ingestible dosage form articles suitable for the delivery of one or more medicaments or other active materials.

Claim (Index 10):
The formulation according to  claim 9 , wherein the active ingredient is at least one active ingredient selected from opioids and morphine derivatives; antidepressants; stimulants; hallucinogenics; hypnotics; and tranquilizers, amphetamine, alprazolam, codeine, diazepam, fentanyl and analogs thereof, hydrocodone, hydromorphone HCl, lorazepam, meperidine, morphine, methylphenidate, methadone, nitrazepam, oxycodone HCL, oxymorphone, propoxyphene, temazepam, tramadol, zolpidem, and zopidcone.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 97.0
- Lexical Diversity: 1.06897
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15591677', '15943131', '11596123', '15257972', '13212679']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7363548245566114
- 35 USC 102 Novelty (BERT): 0.5248655487637697
- Combined Prediction Score: 0.7152058969773273
- Mean Citation Score: 236.102808
- Max Citation Score: 321.64868
- Similarity Product: 203.55223935047627

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test